CleanBrands
Founded Year
2006Stage
Other Investors | AliveAbout CleanBrands
CleanBrands is a designer and manufacturer of allergy barrier bedding products. Founded in 2006, CleanBrands LLC is a Providence, Rhode Island based company that designs and manufactures the world's most innovative and advanced products devoted to improving the health and comfort of the sleep environment. Leveraging a breakthrough, patented fabric technology called MicronOne(R), the company's CleanRest(R), Healthy Zzz(TM) and BeneSleep(R) brands of bedding products provide the world's most effective and comfortable barrier against the millions of toxins and allergens that naturally accumulate inside mattresses and pillows. CleanBrands MicronOne(R) technology was designed by a thirdgeneration textile innovator, backed by science, and recommended by physicians, MicronOne(R) products work.
CleanBrands Patents
CleanBrands has filed 3 patents.

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
4/14/2017 | 6/23/2020 | Bedding, Allergology, Textile closures, Parasitic flies, Hippoboscidae | Grant |
Application Date | 4/14/2017 |
---|---|
Grant Date | 6/23/2020 |
Title | |
Related Topics | Bedding, Allergology, Textile closures, Parasitic flies, Hippoboscidae |
Status | Grant |
Latest CleanBrands News
Jun 3, 2022
Items from CleanBrands, Hotel Equities, IHG and more Read More The post Partner news appeared first on hotelbusiness.com.
CleanBrands Frequently Asked Questions (FAQ)
When was CleanBrands founded?
CleanBrands was founded in 2006.
Where is CleanBrands's headquarters?
CleanBrands's headquarters is located at 400 Massasoit Avenue, East Providence.
What is CleanBrands's latest funding round?
CleanBrands's latest funding round is Other Investors.
Who are the investors of CleanBrands?
Investors of CleanBrands include Northbridge Equity Partners.
Who are CleanBrands's competitors?
Competitors of CleanBrands include SafeRest and 4 more.
Compare CleanBrands to Competitors
Mercator MedSystems has developed a broad-based therapeutic platform that allows clinicians to accurately and efficiently deliver drugs and biologics such as stem cells to tissues deep in the body, treating the root cause of significant medical conditions. The company utilizes its family of Micro-Infusion Catheters for targeted treatments via the vascular system, including peripheral artery disease (PAD) and resistant hypertension (HTN); and via the bronchial tree, including malignant airway obstruction secondary to lung cancer. The company's 510(k)-cleared and CE-Marked Cricket and Bullfrog Micro-Infusion Catheters are vascular-access systems that are able to inject drugs, genes, and cells safely through vessel walls into deep tissues without major surgery.
InterRad Medical is developing a catheter anchoring device called SecurAcath Catheter Retention System. The SecurAcath System is a new and method for holding catheters in place over and extended time. The SecurAcath System aims to utilize a very small anchor that deploys just under the skin to hold a catheter securely in place.
Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.
IntraTherm is focused on continuous improvement of the medical device industry through the introduction of processes and products that aid surgeons and patients in their fight against cancer. The company's product is designed to complement surgery by sterilizing the site of surgery via a controllable and predictable thermal ablation device, with less than minimal short term, and without long term side effects.

OrthAlign provides orthopedic surgeons with user-friendly and cost-effect technology for precise alignment.
Molnlycke Health Care is a manufacturer of single-use surgical and wound care products. The company's products help patients feel less pain and aid healthcare professionals to safer and more efficient surgery.